SNCAIP and Parkinson disease: Drawing a parallel to the activation of GSK3β and CDK5 in neurodegenerative diseases, particularly the hyperphosphorylation of tau in AD [44], it is plausible that synphilin-1 may also undergo hyperphosphorylation in PD.